24 funds hold it.Insiders net selling.
Net selling: insiders sold $2.5M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsLast report
Aug 6, 2026
Period ending
Jun 30, 2026
Earnings per share
$1.21 expected
Revenue
Financial statements: Alpha Vantage
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $1.23 / $1.21Yahoo Finance | +2.05% beat | $308.0M No estimate | Unavailable |
| Mar 28, 2026 | May 7, 2026 | $1.09 / $1.01Yahoo Finance | +8.17% beat | $294.2M No estimateSEC filing | Unavailable |
| Dec 27, 2025 | Feb 5, 2026 | $1.21 / $1.15Yahoo Finance | +5.16% beat | $302.5M No estimateSEC filing | Unavailable |
| Sep 27, 2025 | Nov 6, 2025 | $1.09 / $1.06Yahoo Finance | +2.59% beat | $292.5M No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Aug 7, 2025 | $0.51 / $0.34Alpha Vantage | +50.00% beat | $282.8M No estimate | Unavailable |
| Mar 29, 2025 | May 8, 2025 | $0.90 / $0.86Alpha Vantage | +4.65% beat | $266.6M No estimateSEC filing | Unavailable |
| Dec 28, 2024 | Feb 6, 2025 | $0.92 / $0.86Alpha Vantage | +6.98% beat | $267.2M No estimateSEC filing | Unavailable |
| Sep 28, 2024 | Nov 7, 2024 | $0.81 / $0.75Alpha Vantage | +8.00% beat | $257.7M No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $292.5M | $302.5M | $294.2M | $308.0M |
| Cost of what it sold | $167.9M | $170.8M | $160.9M | $162.2M |
| Gross profit | $124.6M | $131.7M | $133.3M | $145.8M |
| What it spent | ||||
| Research and development | $94.4M | $95.1M | $94.5M | $97.8M |
| Sales and admin | $46.2M | $47.8M | $49.6M | $100.9M |
| Other operating costs | $7.2M | $3.9M | $1.9M | -$36.8M |
| Total operating expenses | $147.8M | $146.8M | $146.0M | $161.9M |
| What was left | ||||
| Operating profit | -$23.2M | -$15.1M | -$12.7M | -$16.1M |
| Interest on debt | $500.0K | $2.4M | $2.5M | $11.9M |
| Profit before tax | -$22.7M | -$17.5M | -$15.2M | -$24.0M |
| Tax | -$2.1M | -$2.7M | -$7.2M | $423.4M |
| Net profit | -$20.6M | -$14.8M | -$8.0M | -$447.4M |
| EBITDA | $20.5M | $26.5M | $16.2M | $19.4M |
This stock is in a strong uptrend, and looks oversold after a sharp drop.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace